TIL FY 2022 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6M

Operating Income

-$206M

Net Income

-$223M

EPS (Diluted)

$-34.46

Cash Flow

Operating Cash Flow

-$180M

Free Cash Flow

-$265M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$482M

Total Liabilities

$119M

Stockholders' Equity

$364M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6M	$0	—
Operating Income	-$206M	-$156M	-32.5%
Net Income	-$223M	-$157M	-42.3%